VHL is a major tumour suppressor while FBXL4 has been linked to early‐onset mitochondrial encephalomyopathy, also referred to as mitochondrial DNA depletion syndrome 13 (Bonnen et al, 2013; Gai et al, 2013; Gossage et al, 2015). Here, VHL is linked to neoplasm.